WallStreetZenWallStreetZen

Sectors & IndustriesHealthcareDrug Manufacturers - Specialty & Generic
Best Pharmaceutical Stocks to Buy Now (2023)
Top pharmaceutical stocks in 2023 ranked by overall Zen Score. See the best pharmaceutical stocks to buy now, according to analyst forecasts for the drug manufacturers - specialty & generic industry.

Industry: Drug Manufacturers - Spec...
Ticker
Company
Country
Market Cap
Shares
Institutional %
Insider %
Net Insider (L12M)
Net Insider (L3M)
RDY
DR REDDYS LABORATORIES LTD
India
$8.88B166,425,8499.81%0.00%
VTRS
VIATRIS INC
United States
$14.42B1,212,684,59874.75%17.41%Net SellingNet Selling
PAHC
PHIBRO ANIMAL HEALTH CORP
United States
$617.68M40,503,60844.08%55.92%
ACRX
ACELRX PHARMACEUTICALS INC
United States
$14.82M7,449,36629.75%70.25%Net Selling
IRWD
IRONWOOD PHARMACEUTICALS INC
United States
$1.76B153,395,47772.99%27.01%Net SellingNet Selling
OGI
ORGANIGRAM HOLDINGS INC
Canada
$288.75M313,856,91210.98%0.00%
AMPH
AMPHASTAR PHARMACEUTICALS INC
United States
$1.48B48,331,18653.09%46.91%Net SellingNet Selling
ASRT
ASSERTIO HOLDINGS INC
United States
$193.66M48,293,61333.74%38.89%Net Selling
SLDB
SOLID BIOSCIENCES INC
United States
$57.57M7,534,89251.87%48.13%Net BuyingNet Buying
CRON
CRONOS GROUP INC
Canada
$942.38M378,467,86711.93%48.43%Net BuyingNet Buying
PRPH
PROPHASE LABS INC
United States
$131.52M16,277,76416.50%62.57%Net BuyingNet Buying
ORGO
ORGANOGENESIS HOLDINGS INC
United States
$340.38M130,915,0995.93%94.07%Net BuyingNet Buying
EGRX
EAGLE PHARMACEUTICALS INC
United States
$439.29M13,015,85625.61%74.39%Net SellingNet Selling
TLRY
TILRAY BRANDS INC
Canada
$1.98B615,494,62611.52%2.18%Net SellingNet Selling
PCRX
PACIRA BIOSCIENCES INC
United States
$1.81B45,882,08869.33%30.67%Net SellingNet Selling
BHC
BAUSCH HEALTH COMPANIES INC
Canada
$3.03B361,868,13167.05%30.58%Net SellingNet Buying
SNDL
SNDL INC
Canada
$537.61M236,833,3807.50%0.00%
CGC
CANOPY GROWTH CORP
Canada
$1.42B485,933,24615.64%56.92%Net BuyingNet Selling
CALT
CALLIDITAS THERAPEUTICS AB
Sweden
$586.33M59,106,1881.57%0.00%
ZTS
ZOETIS INC
United States
$76.99B466,071,99590.26%5.50%Net Selling
TARO
TARO PHARMACEUTICAL INDUSTRIES LTD
Israel
$1.15B37,587,23111.39%50.73%
CTLT
CATALENT INC
United States
$9.66B179,963,58978.21%21.79%Net SellingNet Selling
EOLS
EVOLUS INC
United States
$576.53M56,246,57045.41%29.56%Net Selling
PLXP
PLX PHARMA INC
United States
$7.02M29,137,69221.18%24.87%Net Buying
EBS
EMERGENT BIOSOLUTIONS INC
United States
$671.99M49,888,21845.66%54.34%Net SellingNet Selling
EVOK
EVOKE PHARMA INC
United States
$18.45M3,343,0700.52%99.48%
AGRX
AGILE THERAPEUTICS INC
United States
$10.93M40,614,5275.06%94.94%Net Buying
SCYX
SCYNEXIS INC
United States
$56.82M32,656,99249.91%22.69%Net Buying
CLVR
CLEVER LEAVES HOLDINGS INC
United States
$20.97M44,141,65517.27%28.48%Net SellingNet Selling
OPTN
OPTINOSE INC
United States
$148.67M83,520,47139.10%23.02%Net SellingNet Selling
ACB
AURORA CANNABIS INC
Canada
$306.45M300,437,43313.96%0.00%
INCR
INTERCURE LTD
Israel
$169.25M45,133,94510.75%0.00%
GHSI
GUARDION HEALTH SCIENCES INC
United States
$9.34M1,232,01622.99%77.01%Net BuyingNet Buying
RLMD
RELMADA THERAPEUTICS INC
United States
$124.01M30,099,20385.47%2.80%Net BuyingNet Buying
NLTX
NEOLEUKIN THERAPEUTICS INC
United States
$25.56M42,594,60243.95%41.79%Net Selling
THTX
THERATECHNOLOGIES INC
Canada
$91.34M95,141,63923.05%0.00%
ZOM
ZOMEDICA CORP
United States
$252.83M979,949,6689.42%6.70%
SBFM
SUNSHINE BIOPHARMA INC
Canada
$23.26M22,585,6321.90%17.20%Net SellingNet Buying
RMTI
ROCKWELL MEDICAL INC
United States
$19.31M11,632,6737.58%92.42%
PRFX
PAINREFORM LTD
Israel
$5.37M10,634,1661.02%0.00%
DRRX
DURECT CORP
United States
$149.70M22,785,98449.88%50.12%Net Buying
DERM
JOURNEY MEDICAL CORP
United States
$35.41M17,704,32510.61%15.93%Net Buying
ZYNE
ZYNERBA PHARMACEUTICALS INC
United States
$31.20M47,062,71123.15%8.57%Net SellingNet Selling
TXMD
THERAPEUTICSMD INC
United States
$50.55M9,467,1042.38%97.62%Net BuyingNet Selling
AMYT
AMRYT PHARMA PLC
United Kingdom
$935.91M319,858,44714.26%0.00%
SISI
SHINECO INC
China
$15.91M16,397,3560.94%52.21%
PRGO
PERRIGO CO PLC
Ireland
$5.01B134,639,74661.00%39.00%Net BuyingNet Selling
HUGE
FSD PHARMA INC
Canada
$36.32M38,114,2821.65%0.00%
HEXO
HEXO CORP
Canada
$68.26M42,927,745100.00%0.00%
RDHL
REDHILL BIOPHARMA LTD
Israel
$11.93M568,308,0000.48%0.00%
TKNO
ALPHA TEKNOVA INC
United States
$169.91M28,130,48422.70%75.50%Net BuyingNet Buying
KMDA
KAMADA LTD
Israel
$199.36M44,799,79415.29%0.00%
SUPN
SUPERNUS PHARMACEUTICALS INC
United States
$2.20B54,058,13844.56%55.44%Net SellingNet Buying
SCTL
SOCIETAL CDMO INC
United States
$76.55M56,700,56529.81%70.19%Net SellingNet Selling
MDVL
MEDAVAIL HOLDINGS INC
United States
$38.18M80,045,69636.12%63.88%Net Buying
QLI
QILIAN INTERNATIONAL HOLDING GROUP LTD
China
$47.55M35,750,0000.09%0.00%
CPIX
CUMBERLAND PHARMACEUTICALS INC
United States
$39.49M14,464,12716.91%57.22%Net BuyingNet Buying
PROC
PROCAPS GROUP SA
Luxembourg
$486.27M112,824,1830.95%76.27%
PETQ
PETIQ INC
United States
$344.28M29,226,00884.12%15.88%Net BuyingNet Selling
JUPW
JUPITER WELLNESS INC
United States
$14.10M21,888,88814.28%35.76%Net Buying
ANIP
ANI PHARMACEUTICALS INC
United States
$761.63M17,464,66917.36%82.64%Net SellingNet Selling
BFRI
BIOFRONTERA INC
United States
$24.51M26,699,0023.20%30.60%
HROW
HARROW HEALTH INC
United States
$403.80M27,413,65423.42%76.58%Net BuyingNet Buying
CRDL
CARDIOL THERAPEUTICS INC
Canada
$44.68M63,562,7787.48%0.00%
EVO
EVOTEC SE
Germany
$3.60B176,952,6532.79%0.00%
FLGC
FLORA GROWTH CORP
Canada
$20.51M77,379,0005.66%11.10%
HAPP
HAPPINESS DEVELOPMENT GROUP LTD
China
$24.16M3,954,98415.20%0.00%
IXHL
INCANNEX HEALTHCARE LTD
Australia
$13.93M204,238,2550.02%0.00%
SXTC
CHINA SXT PHARMACEUTICALS INC
China
$1.11M2,031,3930.00%0.00%
CYTH
CYCLO THERAPEUTICS INC
United States
$13.91M8,481,8480.52%99.48%Net Buying
YCBD
CBDMD INC
United States
$19.30M60,682,26212.03%87.97%
COLL
COLLEGIUM PHARMACEUTICAL INC
United States
$949.75M33,571,92356.89%43.11%Net SellingNet Selling
EMBC
EMBECTA CORP
United States
$1.56B57,074,07394.72%0.83%Net SellingNet Selling
XXII
22ND CENTURY GROUP INC
United States
$238.98M215,301,60320.63%15.41%Net Selling
ADMP
ADAMIS PHARMACEUTICALS CORP
United States
$29.40M149,983,2658.57%32.51%Net Selling
ATNX
ATHENEX INC
United States
$30.54M157,410,09830.48%25.47%Net BuyingNet Buying
VERU
VERU INC
United States
$475.68M80,623,12848.60%51.40%Net Buying
UPXI
UPEXI INC
United States
$56.34M17,960,7482.84%38.03%Net BuyingNet Buying
SNOA
SONOMA PHARMACEUTICALS INC
United States
$6.27M3,102,9724.97%95.03%
PTPI
PETROS PHARMACEUTICALS INC
United States
$5.45M2,070,80210.82%89.18%
RGC
REGENCELL BIOSCIENCE HOLDINGS LTD
Hong Kong
$390.13M13,012,8660.06%0.00%
TAK
TAKEDA PHARMACEUTICAL CO LTD
Japan
$53.42B1,666,098,4373.82%0.00%
CPHI
CHINA PHARMA HOLDINGS INC
China
$5.32M51,642,5301.13%66.28%
AKAN
AKANDA CORP
United Kingdom
$9.94M28,909,0260.35%0.00%
LCI
LANNETT CO INC
United States
$23.22M43,002,61328.46%71.54%Net BuyingNet Buying
NEPT
NEPTUNE WELLNESS SOLUTIONS INC
Canada
$9.03M11,725,4513.68%43.92%Net SellingNet Selling
BGXX
BRIGHT GREEN CORP
United States
$85.52M169,342,3008.47%74.43%
COSM
COSMOS HEALTH INC
United States
$21.92M3,351,8995.85%34.61%Net BuyingNet Buying
ELAN
ELANCO ANIMAL HEALTH INC
United States
$6.67B474,205,43090.35%9.65%Net SellingNet Selling
ALIM
ALIMERA SCIENCES INC
United States
$18.22M7,008,4821.99%98.01%Net SellingNet Buying
AVDL
AVADEL PHARMACEUTICALS PLC
Ireland
$455.93M61,778,73250.80%21.15%Net BuyingNet Buying
MNK
MALLINCKRODT PLC
Ireland
$100.10M13,170,9320.40%8.45%
AMRX
AMNEAL PHARMACEUTICALS INC
$649.69M303,592,67932.49%67.51%Net SellingNet Selling
TEVA
TEVA PHARMACEUTICAL INDUSTRIES LTD
Israel
$11.53B1,110,644,80950.39%0.75%Net Selling
ALVO
ALVOTECH
Luxembourg
$2.64B223,718,8979.28%0.00%

Pharmaceutical Stocks FAQ

What are the best pharmaceutical stocks to buy right now in Jan 2023?

According to Zen Score, the 3 best pharma stocks to buy right now are:

1. Dr Reddys Laboratories (NYSE:RDY)


Dr Reddys Laboratories (NYSE:RDY) is the top pharmaceutical stock with a Zen Score of 59, which is 31 points higher than the pharmaceutical industry average of 28. It passed 22 out of 38 due diligence checks and has strong fundamentals. Dr Reddys Laboratories has seen its stock lose -3.6% over the past year, overperforming other pharmaceutical stocks by 26 percentage points.

Dr Reddys Laboratories has an average 1 year price target of $67.00, an upside of 25.61% from Dr Reddys Laboratories's current stock price of $53.34.

Dr Reddys Laboratories stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 1 analyst covering Dr Reddys Laboratories, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the second best pharmaceutical stock with a Zen Score of 53, which is 25 points higher than the pharmaceutical industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Viatris has seen its stock lose -18.51% over the past year, overperforming other pharmaceutical stocks by 11 percentage points.

Viatris has an average 1 year price target of $13.38, an upside of 12.49% from Viatris's current stock price of $11.89.

Viatris stock has a consensus Buy recommendation according to Wall Street analysts. Of the 9 analysts covering Viatris, 22.22% have issued a Strong Buy rating, 11.11% have issued a Buy, 66.67% have issued a hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) is the third best pharmaceutical stock with a Zen Score of 51, which is 23 points higher than the pharmaceutical industry average of 28. It passed 18 out of 38 due diligence checks and has strong fundamentals. Phibro Animal Health has seen its stock lose -19.95% over the past year, overperforming other pharmaceutical stocks by 10 percentage points.

Phibro Animal Health has an average 1 year price target of $18.33, an upside of 20.22% from Phibro Animal Health's current stock price of $15.25.

Phibro Animal Health stock has a consensus Hold recommendation according to Wall Street analysts. Of the 3 analysts covering Phibro Animal Health, 33.33% have issued a Strong Buy rating, 0% have issued a Buy, 33.33% have issued a hold, while 0% have issued a Sell rating, and 33.33% have issued a Strong Sell.

What are the pharmaceutical stocks with highest dividends?

Out of 6 pharmaceutical stocks that have issued dividends in the past year, the 3 pharmaceutical stocks with the highest dividend yields are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) has an annual dividend yield of 4.04%, which is 2 percentage points higher than the pharmaceutical industry average of 2.36%. Viatris's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Viatris's dividend has shown consistent growth over the last 10 years.

Viatris's dividend payout ratio of 71.2% indicates that its dividend yield is sustainable for the long-term.

2. Prophase Labs (NASDAQ:PRPH)


Prophase Labs (NASDAQ:PRPH) has an annual dividend yield of 3.71%, which is 1 percentage points higher than the pharmaceutical industry average of 2.36%.

Prophase Labs's dividend payout ratio of 29.3% indicates that its dividend yield is sustainable for the long-term.

3. Phibro Animal Health (NASDAQ:PAHC)


Phibro Animal Health (NASDAQ:PAHC) has an annual dividend yield of 3.15%, which is 1 percentage points higher than the pharmaceutical industry average of 2.36%. Phibro Animal Health's dividend payout is stable, having never dropped by more than 10% in the last 10 years. Phibro Animal Health's dividend has shown consistent growth over the last 10 years.

Phibro Animal Health's dividend payout ratio of 41.7% indicates that its dividend yield is sustainable for the long-term.

Why are pharmaceutical stocks up?

Pharmaceutical stocks were up 0.27% in the last day, and up 2.54% over the last week. Viatris was the among the top gainers in the drug manufacturers - specialty & generic industry, gaining 2.15% yesterday.

Viatris shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised the price target from $13 to $15.

What are the most undervalued pharmaceutical stocks?

Based on WallStreetZen's Valuation Score, the 3 most undervalued pharmaceutical stocks right now are:

1. Viatris (NASDAQ:VTRS)


Viatris (NASDAQ:VTRS) is the most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Viatris has a valuation score of 86, which is 57 points higher than the pharmaceutical industry average of 29. It passed 6 out of 7 valuation due diligence checks.

Viatris's stock has dropped -18.51% in the past year. It has overperformed other stocks in the pharmaceutical industry by 11 percentage points.

2. Emergent Biosolutions (NYSE:EBS)


Emergent Biosolutions (NYSE:EBS) is the second most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Emergent Biosolutions has a valuation score of 71, which is 42 points higher than the pharmaceutical industry average of 29. It passed 5 out of 7 valuation due diligence checks.

Emergent Biosolutions's stock has dropped -69.55% in the past year. It has underperformed other stocks in the pharmaceutical industry by -40 percentage points.

3. Acelrx Pharmaceuticals (NASDAQ:ACRX)


Acelrx Pharmaceuticals (NASDAQ:ACRX) is the third most undervalued pharmaceutical stock based on WallStreetZen's Valuation Score. Acelrx Pharmaceuticals has a valuation score of 71, which is 42 points higher than the pharmaceutical industry average of 29. It passed 5 out of 7 valuation due diligence checks.

Acelrx Pharmaceuticals's stock has dropped -76.35% in the past year. It has underperformed other stocks in the pharmaceutical industry by -47 percentage points.

Are pharmaceutical stocks a good buy now?

45% of pharmaceutical stocks rated by analysts are a strong buy right now. On average, analysts expect pharmaceutical stocks to rise by 55.72% over the next year.

What is the average p/e ratio of the drug manufacturers - specialty & generic industry?

The average P/E ratio of the drug manufacturers - specialty & generic industry is 20.07x.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.